Editorial
Urachal carcinoma: towards a precision medicine
Translational Cancer Research
2016;
5
(Suppl 7)
:S1307-S1310
.
(29 December 2016)
Different intellectual outcomes in molecular subgroups of medulloblastoma
Translational Cancer Research
2016;
5
(Suppl 7)
:S1311-S1314
.
(29 December 2016)
Indolence versus aggression in non-small cell lung cancer: defining heterogeneity to impact clinical outcomes
Translational Cancer Research
2016;
5
(Suppl 7)
:S1315-S1319
.
(29 December 2016)
Should optimal supportive care alone be the standard of care for brain metastases patients from non-small cell lung cancer, who are not eligible for radiosurgery or surgery?
Translational Cancer Research
2016;
5
(Suppl 7)
:S1320-S1322
.
(29 December 2016)
BRAF inhibitors in advanced BRAF-positive non-small cell lung cancer
Translational Cancer Research
2016;
5
(Suppl 7)
:S1323-S1327
.
(29 December 2016)
Cell intrinsic PD-1 checkpoint blockade releases the brake on human chimeric antigen receptor (CAR) T cells for solid tumors
Translational Cancer Research
2016;
5
(Suppl 7)
:S1328-S1332
.
(29 December 2016)
Personalized peptide vaccine in prostate cancer: capitalizing on existing immunity
Translational Cancer Research
2016;
5
(Suppl 7)
:S1333-S1335
.
(29 December 2016)
“Simplicity is complexity resolved”: the case of postoperative radiation therapy after breast conservation
Translational Cancer Research
2016;
5
(Suppl 7)
:S1336-S1339
.
(29 December 2016)
Emerging multikinase inhibitors for the treatment of differentiated thyroid cancer: whom to treat?
Translational Cancer Research
2016;
5
(Suppl 7)
:S1340-S1344
.
(29 December 2016)
Routine prophylactic drainage in rectal surgery—closing the chapter?
Translational Cancer Research
2016;
5
(Suppl 7)
:S1345-S1348
.
(29 December 2016)
Tumor treating fields—effective, but at what cost?
Translational Cancer Research
2016;
5
(Suppl 7)
:S1349-S1353
.
(29 December 2016)
A cytological link between radioresistance and autophagy
Translational Cancer Research
2016;
5
(Suppl 7)
:S1354-S1357
.
(29 December 2016)
Hypoxia-induced DNA hypermethylation: another reason to normalize tumor vessels
Translational Cancer Research
2016;
5
(Suppl 7)
:S1358-S1362
.
(29 December 2016)
Relapsed small cell lung cancer: is more better?
Translational Cancer Research
2016;
5
(Suppl 7)
:S1363-S1365
.
(29 December 2016)
JMJD3 histone demethylase—a potential therapeutic target for metastatic hepatocellular carcinoma?
Translational Cancer Research
2016;
5
(Suppl 7)
:S1366-S1368
.
(29 December 2016)
Is combined chemotherapy with cisplatin, etoposide and irinotecan the new standard treatment for patients with sensitive relapsed small cell lung cancer?
Translational Cancer Research
2016;
5
(Suppl 7)
:S1369-S1371
.
(29 December 2016)
Hypofractionated radiotherapy for breast cancer: how to evaluate chronic toxicity and cosmesis?
Translational Cancer Research
2016;
5
(Suppl 7)
:S1372-S1376
.
(29 December 2016)
Sentinel node biopsy in combination with extended pelvic lymph node dissection for men with prostate cancer at risk of nodal involvement
Translational Cancer Research
2016;
5
(Suppl 7)
:S1377-S1379
.
(29 December 2016)
Omission of adjuvant radiotherapy in early-stage breast cancer: have we identified a subgroup?
Translational Cancer Research
2016;
5
(Suppl 7)
:S1380-S1382
.
(29 December 2016)
Trunk or branch? Identifying and targeting intratumoral heterogeneity in hepatocellular carcinoma using genomics and patient derived primary cancer cells
Translational Cancer Research
2016;
5
(Suppl 7)
:S1383-S1386
.
(29 December 2016)
Micropapillary urothelial carcinoma: is molecular hair-splitting on target?
Translational Cancer Research
2016;
5
(Suppl 7)
:S1387-S1392
.
(29 December 2016)
Distinct benefit from crizotinib in lung cancer patients carrying distinct ALK translocations: is fluorescent hybridization in situ testing still sufficient to guide clinical decisions?
Translational Cancer Research
2016;
5
(Suppl 7)
:S1393-S1395
.
(29 December 2016)
PD-L1 is a diverse molecule regulating both tumor-intrinsic signaling and adaptive immunosuppression
Translational Cancer Research
2016;
5
(Suppl 7)
:S1396-S1399
.
(29 December 2016)
Transgenic mouse models of Idh-mutated neural stem cells: an appropriate model for low grade glioma?
Translational Cancer Research
2016;
5
(Suppl 7)
:S1400-S1403
.
(29 December 2016)
Pelvic drain after colorectal anastomosis: useful or useless
Translational Cancer Research
2016;
5
(Suppl 7)
:S1404-S1407
.
(29 December 2016)
A transcriptional-microRNA network for β-catenin-driven stemness in hepatocellular carcinoma
Translational Cancer Research
2016;
5
(Suppl 7)
:S1408-S1412
.
(29 December 2016)
Adding chemotherapy to TKI: can we improve first-line treatment for EGFR-mutated NSCLC patients?
Translational Cancer Research
2016;
5
(Suppl 7)
:S1413-S1416
.
(29 December 2016)
Commentary
Predictive biomarkers for prostate brachytherapy—not there yet
Translational Cancer Research
2016;
5
(Suppl 7)
:S1417-S1419
.
(29 December 2016)
PGC1α curtails prostate cancer metastasis via metabolic rewiring
Translational Cancer Research
2016;
5
(Suppl 7)
:S1420-S1423
.
(29 December 2016)
How far have we achieved by systemic therapy for recurrent/metastatic nasopharyngeal carcinoma?
Translational Cancer Research
2016;
5
(Suppl 7)
:S1424-S1427
.
(29 December 2016)
A new approach to high risk pediatric acute lymphoblastic leukemia?
Translational Cancer Research
2016;
5
(Suppl 7)
:S1428-S1432
.
(29 December 2016)
When tumors are (co-)opting to resist anti-angiogenic treatment
Translational Cancer Research
2016;
5
(Suppl 7)
:S1433-S1436
.
(29 December 2016)
Versikine, a proteolysis product of Versican: novel therapeutics for multiple myeloma
Translational Cancer Research
2016;
5
(Suppl 7)
:S1437-S1439
.
(29 December 2016)
The role of long noncoding RNA FOXF1-AS1 as a tumor suppressor in non-small cell lung cancer
Translational Cancer Research
2016;
5
(Suppl 7)
:S1440-S1442
.
(29 December 2016)
Checkpoints inhibitors in first line therapy of metastatic non-small cell lung cancer patients
Translational Cancer Research
2016;
5
(Suppl 7)
:S1443-S1448
.
(29 December 2016)
Trimming the fat in non-small cell lung cancer: a new small molecule inhibitor of acetyl-CoA carboxylase to target fatty acid synthesis
Translational Cancer Research
2016;
5
(Suppl 7)
:S1449-S1452
.
(29 December 2016)
Repurposing multiple sclerosis drug dimethyl fumarate, a promising fast track candidate for systemic cutaneous T cell lymphoma treatment
Translational Cancer Research
2016;
5
(Suppl 7)
:S1453-S1456
.
(29 December 2016)
The Wnt/β-catenin pathway is activated by miR-1246 in liver cancer stem cells
Translational Cancer Research
2016;
5
(Suppl 7)
:S1457-S1460
.
(29 December 2016)
Targeting B-Raf kinase for thyroid cancer treatment: promise and challenge
Translational Cancer Research
2016;
5
(Suppl 7)
:S1461-S1464
.
(29 December 2016)
Toward the clarification of the role of whole-brain radiation therapy for brain metastases from non-small cell lung cancer: a comment about the QUARTZ trial
Translational Cancer Research
2016;
5
(Suppl 7)
:S1465-S1468
.
(29 December 2016)
Utility of gene expression signature in treatment decision of breast cancer
Translational Cancer Research
2016;
5
(Suppl 7)
:S1469-S1472
.
(29 December 2016)
Major thoracic surgery in patients under antiplatelet therapy
Translational Cancer Research
2016;
5
(Suppl 7)
:S1473-S1475
.
(29 December 2016)
Empiric H. pylori therapy—10-day concomitant, bismuth quadruple or 14-day triple therapy: none is best
Translational Cancer Research
2016;
5
(Suppl 7)
:S1476-S1478
.
(29 December 2016)
miRNA transported by exosomes: a key machinery in tumor microenvironment mediated chemoresistance
Translational Cancer Research
2016;
5
(Suppl 7)
:S1479-S1482
.
(29 December 2016)
Rac1 and EMT: a dangerous liaison?
Translational Cancer Research
2016;
5
(Suppl 7)
:S1483-S1485
.
(29 December 2016)
Secreted reporter proteins, a valuable complementary tool for non-invasive preclinical monitoring of brain tumour growth
Translational Cancer Research
2016;
5
(Suppl 7)
:S1486-S1488
.
(29 December 2016)
[18F]-choline PET/CT as an imaging biomarker for primary liver cancers
Translational Cancer Research
2016;
5
(Suppl 7)
:S1489-S1492
.
(29 December 2016)
Direct acting antivirals for hepatitis c and hepatocellular carcinoma recurrence: an unsolved mystery
Translational Cancer Research
2016;
5
(Suppl 7)
:S1493-S1495
.
(29 December 2016)
Perspective
Perspective on the regulatory role of UGT2B28 as a conjugating enzyme in the progression of prostate cancer
Translational Cancer Research
2016;
5
(Suppl 7)
:S1496-S1502
.
(29 December 2016)
HIF-pathway proteins: central regulators of tumor immunology
Translational Cancer Research
2016;
5
(Suppl 7)
:S1503-S1508
.
(29 December 2016)
Small molecule inhibition of speckle-type POZ protein-substrate interactions for the treatment of renal cell carcinoma
Translational Cancer Research
2016;
5
(Suppl 7)
:S1509-S1514
.
(29 December 2016)
Tumor intrinsic resistance to anti-programmed death 1
Translational Cancer Research
2016;
5
(Suppl 7)
:S1515-S1520
.
(29 December 2016)
Transoral endoscopic thyroidectomy: current state of the art—a systematic literature review and results of a bi-center study
Translational Cancer Research
2016;
5
(Suppl 7)
:S1521-S1530
.
(29 December 2016)
DNA hypermethylation of tumor suppressor genes as an early lung cancer biomarker
Translational Cancer Research
2016;
5
(Suppl 7)
:S1531-S1538
.
(29 December 2016)
Evolving concepts of micropapillary variant urothelial carcinoma
Translational Cancer Research
2016;
5
(Suppl 7)
:S1539-S1542
.
(29 December 2016)
Programmed death ligand 1 expression and human papillomavirus status: penile cancer prognostic factors and new therapeutic opportunities
Translational Cancer Research
2016;
5
(Suppl 7)
:S1543-S1545
.
(29 December 2016)
Correspondence
Response letter: “epigenetic modulation of a miR-296-5p:HMGA1 axis regulates Sox2 expression and glioblastoma stem cells”
Translational Cancer Research
2016;
5
(Suppl 7)
:S1546-S1548
.
(29 December 2016)
Why observational studies are important in comparative effectiveness research: the effect of breast-conserving therapy and mastectomy in the real world
Translational Cancer Research
2016;
5
(Suppl 7)
:S1549-S1550
.
(29 December 2016)
DDR1 and Notch: a multifaceted synergy
Translational Cancer Research
2016;
5
(Suppl 7)
:S1551-S1553
.
(29 December 2016)
Response letter: Bronchial sleeve resection or pneumonectomy for non-small cell lung cancer? Pneumonectomy is still a valid choice
Translational Cancer Research
2016;
5
(Suppl 7)
:S1554-S1555
.
(29 December 2016)
Disclosure:
This supplement was published without any sponsorship or funding.
